mRNA expression profile in vascular smooth muscle cells (VSMCs) after inducing calcification
收藏资源简介:
Vascular calcification (VC) is often associated with cardiovascular and metabolic diseases. However, the molecular mechanisms linking VC to these diseases have yet to be elucidated. Here we report that MDM2-induced polyubiquitination of histone deacetylase 1 (HDAC1) mediates VC. Loss of HDAC1 activity via either chemical inhibitor or genetic ablation enhanced VC. HDAC1 protein, but not mRNA, was reduced in cell and animal calcification models and in human calcified coronary artery. In the calcification-provoking condition, proteasomal degradation of HDAC1 preceded VC. The calcification-provoking condition induced MDM2 E3 ligase, which then resulted in HDAC1 K74 polyubiquitination. Overexpression of MDM2 enhanced VC, whereas loss of MDM2 blunted it. Decoy peptides spanning HDAC1 K74 and RG 7112, an MDM2 inhibitor, prevented VC in vivo and in vitro. These results demonstrate a previously unknown ubiquitination pathway and suggest MDM2-mediated HDAC1 polyubiquitination as a new therapeutic target in VC.
血管钙化(Vascular calcification, VC)常与心血管疾病及代谢性疾病密切相关,但目前VC与这些疾病之间的潜在分子机制仍尚未阐明。本研究揭示,MDM2介导的组蛋白去乙酰化酶1(histone deacetylase 1, HDAC1)多泛素化修饰可调控血管钙化进程。通过化学抑制剂处理或基因敲除抑制HDAC1活性,可显著促进血管钙化的发生。在细胞钙化模型、动物钙化模型以及人类钙化冠状动脉组织中,HDAC1的蛋白水平(而非mRNA水平)显著下调。在促钙化条件下,HDAC1的蛋白酶体降解早于血管钙化发生。促钙化条件会诱导MDM2 E3泛素连接酶的表达,进而引发HDAC1第74位赖氨酸位点的多泛素化修饰。过表达MDM2可增强血管钙化,而敲除或敲低MDM2则会抑制该进程。靶向HDAC1 K74位点的诱饵肽以及MDM2抑制剂RG 7112,可在体内外实验中阻断血管钙化的发生。上述研究结果揭示了一条此前未被报道的泛素化通路,并提示MDM2介导的HDAC1多泛素化修饰可作为血管钙化治疗的全新潜在靶点。



